Kintara Therapeutics Inc. (KTRA): Recent activity puts odds in your favor – Invest Chronicle
Home  »  Finance   »  Kintara Therapeutics Inc. (KTRA): Recent activity ...

Kintara Therapeutics Inc. (KTRA): Recent activity puts odds in your favor

Let’s start up with the current stock price of Kintara Therapeutics Inc. (KTRA), which is $0.24 to be very precise. The Stock rose vividly during the last session to $0.26 after opening rate of $0.2075 while the lowest price it went was recorded $0.2075 before closing at $0.20.Recently in News on June 21, 2022, Kintara Therapeutics to Present at the Alliance Global Partners Summer Healthcare Conference. Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that President and CEO Robert E. Hoffman will present a corporate overview at the Alliance Global Partners Summer Healthcare Conference. The conference is being held virtually on June 21 – 22, 2022. You can read further details here

Kintara Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.8400 on 04/11/22, with the lowest value was $0.1406 for the same time period, recorded on 05/12/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Kintara Therapeutics Inc. (KTRA) full year performance was -88.69%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Kintara Therapeutics Inc. shares are logging -91.67% during the 52-week period from high price, and 68.92% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.14 and $2.85.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 5159691 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Kintara Therapeutics Inc. (KTRA) recorded performance in the market was -53.43%, having the revenues showcasing -35.50% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 16.15M, as it employees total of 4 workers.

The Analysts eye on Kintara Therapeutics Inc. (KTRA)

During the last month, 0 analysts gave the Kintara Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.3099, with a change in the price was noted -0.16. In a similar fashion, Kintara Therapeutics Inc. posted a movement of -39.80% for the period of last 100 days, recording 2,594,320 in trading volumes.

Technical rundown of Kintara Therapeutics Inc. (KTRA)

Raw Stochastic average of Kintara Therapeutics Inc. in the period of last 50 days is set at 13.85%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 64.69%. In the last 20 days, the company’s Stochastic %K was 47.20% and its Stochastic %D was recorded 45.19%.

Considering, the past performance of Kintara Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -53.43%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -62.18%, alongside a downfall of -88.69% for the period of the last 12 months. The shares increased approximately by 16.54% in the 7-day charts and went down by 48.90% in the period of the last 30 days. Common stock shares were lifted by -35.50% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]